Target intelligence / Profile preview

TMEM167A pseudogene 2 (TMEM167AP2)

Target
TMEM167AP2
Molecular classification
Other (pseudogene)
01

Overview

TMEM167A pseudogene 2 (TMEM167AP2) is classified as a pseudogene; it is a disabled, nonprotein-coding genomic DNA segment derived from the protein-coding gene TMEM167A[1][4]. Pseudogenes typically do not produce functional protein, and most are not considered molecular drug targets[3]. There is no current evidence that TMEM167A pseudogene 2 has any physiological, pathological, or pharmacological function. Its parent gene, TMEM167A (Transmembrane protein 167A), is involved in vesicle transport and the constitutive secretory pathway in the Golgi apparatus, but the pseudogene does not share these activities[2][6][7]. No drugs, biomarkers, or therapeutic relevance are known or reported for TMEM167A pseudogene 2. According to recognized gene annotation resources, TMEM167AP2 is designated as a pseudogene without known coding or regulatory function[1][4]. Thus, this entity is not a valid therapeutic target and should not be included in curated lists of actionable molecular targets.

Other names
TMEM167AP2TMEM167A pseudogene 2
02

Mechanism of action

None

03

Biological functions

None established; pseudogenes are generally considered non-functional, though rare cases of regulatory function are occasionally reported in the literature
04

Disease associations

None documented for TMEM167A pseudogene 2
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on TMEM167A pseudogene 2 (TMEM167AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM167A pseudogene 2 (TMEM167AP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call